IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Foley & Lardner
- Armstrong Teasdale
- Krantz & Berman
- Linklaters LLP
- Cicala Law Firm
- Norton Rose
- Cozen O'Connor
- Steven Williams Law
- Tostrud Law Group
- Kirkland & Ellis
- Steptoe LLP
- Wilson Sonsini
- Cuneo Gilbert
- Freedman Boyd
- Girard Sharp
- Cleary Gottlieb
- Weil Gotshal
- NastLaw
- Pogust Goodhead
- Spiro Harrison
- Welsh & Recker
- DeCotiis FitzPatrick
- Faegre Drinker
- Lite DePalma
- Neal & Harwell
- Stueve Siegel
- Kaplan Fox
- Williams & Connolly
- Berger Montague
- Miller Shah LLP
- Schertler Onorato
- Lieff Cabraser
- Motley Rice
- Cole Schotz
- DiCello Levitt
- Baker Botts
- Fox Rothschild
- Larson King
- Furth Salem
- Hausfeld LLP
- Lockridge Grindal
- Simpson Thacher & Bartlett LLP
- Troutman Pepper
- Calcaterra Pollack
- White and Williams
- Morrison Foerster
- Morgan Lewis
- Napoli Shkolnik
- Arnold & Porter
- Dugan Law Firm
- Nussbaum Law Group
- Kasowitz Benson
- DLA Piper
- Hogan Lovells
- Hagens Berman
- Miller & Chevalier
- Reed Smith
- Marks O'Neill
- Schneider Wallace
- Joseph Saveri Law Firm
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Cotchett Pitre
- Crowell & Moring
- Lowey Dannenberg
- Fine Kaplan
- Grant & Eisenhofer
Companies
- LifeWallet
- Walgreens Boots Alliance Inc.
- The Harvard Drug Group LLC
- Health Care Service Corp.
- Red Oak Sourcing LLC
- Molina Healthcare Inc.
- Bausch Health Cos. Inc.
- Cardinal Health Inc.
Government Agencies
Sectors & Industries:
-
December 19, 2018
Generic-Drug Cos. Want AGs To Shut Up About Price-Fixing
Generic-drug companies facing multidistrict litigation and ongoing probes into alleged price-fixing are tired of hearing about them in the news, according to a brief filed in Pennsylvania federal court Tuesday that argues state attorneys general offices have violated legal and ethical requirements to keep mum.
-
November 15, 2018
Judge Won't Quash AGs' Subpoenas In Generic Pricing MDL
The New York and Connecticut attorneys general can keep sending subpoenas to drugmakers as part of their broader investigations into generic-drug price-fixing, a Pennsylvania federal judge has ruled, despite the drug companies’ concern the investigations were circumventing the discovery process for a sprawling multidistrict litigation.
-
November 05, 2018
Humana Seeks Case's Inclusion In Generic Price-Fixing MDL
Humana on Friday asked the Pennsylvania federal court overseeing the sprawling multidistrict litigation over generic drug prices to formally incorporate its action into the MDL, saying its claims target many of the same drugs that the group of states and proposed classes of drug buyers are targeting.
-
October 17, 2018
20 Drugmakers Must Face Generic Price-Fixing MDL
A Pennsylvania federal court has greenlighted the first round of multidistrict litigation accusing more than 20 generic-drug makers of conspiring to fix their prices, excusing only Teligent Inc. from the antitrust litigation.
-
September 26, 2018
McKesson Is Roped Into Generic-Drug Price-Fixing Row
McKesson Corp. earned billions of dollars by cooperating with an industrywide price-fixing conspiracy among generic-drug makers, according to a proposed class action Tuesday that appeared to be one of the first suits linking a drug distributor to multidistrict litigation over alleged drugmaker collusion.
-
January 03, 2018
Generics Buyers Fight To Keep 2 Drugs In Antitrust MDL
Direct purchaser plaintiffs in a large antitrust class action alleging price-fixing of a variety of generic drugs are pushing back against a motion to dismiss claims over two drugs, telling a Pennsylvania federal judge that the complaints contain more than enough of a basis to open discovery.
-
November 15, 2017
State AGs Want Separate Track In Generic Price-Fixing MDL
State attorneys general accusing 18 drug companies of conspiring to fix the prices of 15 generic drugs urged a Pennsylvania federal judge Tuesday to establish a separate government track within the broader multidistrict litigation, saying they can't yield authority to other entities such as private parties' lead counsel and their allegations are too broad to be litigated drug by drug.
-
October 31, 2017
State AGs Triple Size Of Generic Price-Fixing Litigation
The 46 attorneys general accusing six drug companies of conspiring to fix the price of two generic drugs said Tuesday they're asking a Pennsylvania federal court for permission to massively expand their suit by targeting 12 more drug companies, 13 more drugs, and Mylan and Emcure executives.
-
June 02, 2017
6 Suits Say Mylan, Others Rigged Generic Drug Prices
Mylan Inc., Fougera Pharmaceuticals Inc., Par Pharmaceuticals Inc. and other drugmakers conspired to jack up the prices of certain generic muscle relaxers, skin creams, antidepressants and blood pressure drugs, a Northeast U.S. pharmacy operator said in six separate antitrust lawsuits filed on Thursday as part of multidistrict litigation in Pennsylvania federal court.
-
May 23, 2017
Generic Drug Price-Fixing MDL Fuels Worries For Defendants
The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania's Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous defendants could make it harder for individual companies to avoid getting more deeply embroiled in the litigation.